Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
2.880
0.00 (0.00%)
At close: Feb 3, 2026, 4:00 PM EST
2.890
+0.010 (0.36%)
After-hours: Feb 3, 2026, 7:11 PM EST
Whitehawk Therapeutics Market Cap
Whitehawk Therapeutics has a market cap or net worth of $135.73 million as of February 3, 2026. Its market cap has increased by 75.94% in one year.
Market Cap
135.73M
Enterprise Value
-26.87M
1-Year Change
75.94%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since August 27, 2021, Whitehawk Therapeutics's market cap has decreased from $540.80M to $135.73M, a decrease of -74.90%. That is a compound annual growth rate of -26.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 135.73M | 19.01% |
| Dec 31, 2025 | 114.05M | 46.67% |
| Dec 31, 2024 | 77.76M | 56.96% |
| Dec 29, 2023 | 49.54M | -84.17% |
| Dec 30, 2022 | 312.99M | -37.97% |
| Dec 31, 2021 | 504.59M | -6.70% |
| Aug 27, 2021 | 540.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fate Therapeutics | 141.88M |
| Elicio Therapeutics | 141.55M |
| Cibus | 140.52M |
| Connect Biopharma Holdings | 139.20M |
| Unicycive Therapeutics | 138.62M |
| Adagene | 138.57M |
| Seres Therapeutics | 137.05M |
| Caribou Biosciences | 136.46M |